Literature DB >> 26490391

A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.

Rachel C Challis1, Geisilaine S R Araujo1, Edwin K S Wong1, Holly E Anderson1, Atif Awan2, Anthony M Dorman3, Mary Waldron2, Valerie Wilson1, Vicky Brocklebank1, Lisa Strain1, B Paul Morgan4, Claire L Harris4, Kevin J Marchbank5, Timothy H J Goodship1, David Kavanagh6.   

Abstract

The regulators of complement activation cluster at chromosome 1q32 contains the complement factor H (CFH) and five complement factor H-related (CFHR) genes. This area of the genome arose from several large genomic duplications, and these low-copy repeats can cause genome instability in this region. Genomic disorders affecting these genes have been described in atypical hemolytic uremic syndrome, arising commonly through nonallelic homologous recombination. We describe a novel CFH/CFHR3 hybrid gene secondary to a de novo 6.3-kb deletion that arose through microhomology-mediated end joining rather than nonallelic homologous recombination. We confirmed a transcript from this hybrid gene and showed a secreted protein product that lacks the recognition domain of factor H and exhibits impaired cell surface complement regulation. The fact that the formation of this hybrid gene arose as a de novo event suggests that this cluster is a dynamic area of the genome in which additional genomic disorders may arise.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  complement; genetic renal disease; hemolytic uremic syndrome

Mesh:

Substances:

Year:  2015        PMID: 26490391      PMCID: PMC4884102          DOI: 10.1681/ASN.2015010100

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  32 in total

1.  A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.

Authors:  Tara K Maga; Nicole C Meyer; Craig Belsha; Carla J Nishimura; Yuzhou Zhang; Richard J H Smith
Journal:  Nephrol Dial Transplant       Date:  2010-10-25       Impact factor: 5.992

2.  A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.

Authors:  Nigel J Francis; Bairbre McNicholas; Atif Awan; Mary Waldron; Donal Reddan; Denise Sadlier; David Kavanagh; Lisa Strain; Kevin J Marchbank; Claire L Harris; Timothy H J Goodship
Journal:  Blood       Date:  2011-11-04       Impact factor: 22.113

Review 3.  Complement factor H related proteins (CFHRs).

Authors:  Christine Skerka; Qian Chen; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Mol Immunol       Date:  2013-07-03       Impact factor: 4.407

4.  Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

Authors:  Fadi Fakhouri; Lubka Roumenina; François Provot; Marion Sallée; Sophie Caillard; Lionel Couzi; Marie Essig; David Ribes; Marie-Agnès Dragon-Durey; Frank Bridoux; Eric Rondeau; Veronique Frémeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 10.121

5.  An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).

Authors:  Lars G Fritsche; Nadine Lauer; Andrea Hartmann; Selina Stippa; Claudia N Keilhauer; Martin Oppermann; Manoj K Pandey; Jörg Köhl; Peter F Zipfel; Bernhard H F Weber; Christine Skerka
Journal:  Hum Mol Genet       Date:  2010-09-15       Impact factor: 6.150

6.  Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Elizabeth J Kemp; Elizabeth Mayland; Robin J Winney; Jeremy S Duffield; Graham Warwick; Anna Richards; Roy Ward; Judith A Goodship; Timothy H J Goodship
Journal:  J Am Soc Nephrol       Date:  2005-05-25       Impact factor: 10.121

7.  Structural basis for engagement by complement factor H of C3b on a self surface.

Authors:  Hugh P Morgan; Christoph Q Schmidt; Mara Guariento; Bärbel S Blaum; Dominic Gillespie; Andrew P Herbert; David Kavanagh; Haydyn D T Mertens; Dmitri I Svergun; Conny M Johansson; Dušan Uhrín; Paul N Barlow; Jonathan P Hannan
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

8.  Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.

Authors:  Julian P Venables; Lisa Strain; Danny Routledge; David Bourn; Helen M Powell; Paul Warwicker; Martha L Diaz-Torres; Anne Sampson; Paul Mead; Michelle Webb; Yves Pirson; Michael S Jackson; Anne Hughes; Katrina M Wood; Judith A Goodship; Timothy H J Goodship
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

9.  The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Authors:  Viviana P Ferreira; Andrew P Herbert; Claudio Cortés; Kristi A McKee; Bärbel S Blaum; Stefan T Esswein; Dusan Uhrín; Paul N Barlow; Michael K Pangburn; David Kavanagh
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 10.  Atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Tim H Goodship; Anna Richards
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

View more
  15 in total

Review 1.  CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Authors:  Peter F Zipfel; Thorsten Wiech; Emma D Stea; Christine Skerka
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

Review 2.  Complementopathies.

Authors:  Andrea C Baines; Robert A Brodsky
Journal:  Blood Rev       Date:  2017-02-06       Impact factor: 8.250

3.  Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.

Authors:  Véronique Frémeaux-Bacchi; Anne-Laure Sellier-Leclerc; Paula Vieira-Martins; Sophie Limou; Theresa Kwon; Annie Lahoche; Robert Novo; Brigitte Llanas; François Nobili; Gwenaëlle Roussey; Mathilde Cailliez; Tim Ulinski; Georges Deschênes; Corinne Alberti; François-Xavier Weill; Patricia Mariani; Chantal Loirat
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-23       Impact factor: 8.237

4.  Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family.

Authors:  Stuart Cantsilieris; Bradley J Nelson; John Huddleston; Carl Baker; Lana Harshman; Kelsi Penewit; Katherine M Munson; Melanie Sorensen; AnneMarie E Welch; Vy Dang; Felix Grassmann; Andrea J Richardson; Robyn H Guymer; Tina A Graves-Lindsay; Richard K Wilson; Bernhard H F Weber; Paul N Baird; Rando Allikmets; Evan E Eichler
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

5.  Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease.

Authors:  Rachel C Challis; Troels Ring; Yaobo Xu; Edwin K S Wong; Oliver Flossmann; Ian S D Roberts; Saeed Ahmed; Michael Wetherall; Giedrius Salkus; Vicky Brocklebank; Julian Fester; Lisa Strain; Valerie Wilson; Katrina M Wood; Kevin J Marchbank; Mauro Santibanez-Koref; Timothy H J Goodship; David Kavanagh
Journal:  J Am Soc Nephrol       Date:  2016-12-14       Impact factor: 10.121

Review 6.  Diseases of complement dysregulation-an overview.

Authors:  Edwin K S Wong; David Kavanagh
Journal:  Semin Immunopathol       Date:  2018-01-11       Impact factor: 9.623

7.  Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.

Authors:  Vicky Brocklebank; Sally Johnson; Thomas P Sheerin; Stephen D Marks; Rodney D Gilbert; Kay Tyerman; Meredith Kinoshita; Atif Awan; Amrit Kaur; Nicholas Webb; Shivaram Hegde; Eric Finlay; Maggie Fitzpatrick; Patrick R Walsh; Edwin K S Wong; Caroline Booth; Larissa Kerecuk; Alan D Salama; Mike Almond; Carol Inward; Timothy H Goodship; Neil S Sheerin; Kevin J Marchbank; David Kavanagh
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

8.  Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential.

Authors:  Frances Dowen; Katrina Wood; Alison L Brown; Jennifer Palfrey; David Kavanagh; Vicky Brocklebank
Journal:  Clin Kidney J       Date:  2017-05-08

9.  Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

Authors:  Vicky Brocklebank; David Kavanagh
Journal:  Clin Kidney J       Date:  2017-05-08

10.  High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B.

Authors:  Richard B Pouw; Irene Gómez Delgado; Alberto López Lera; Santiago Rodríguez de Córdoba; Diana Wouters; Taco W Kuijpers; Pilar Sánchez-Corral
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.